Terms: = Thyroid cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
24 results:
1. Correlation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma.
Zhao F; Zhu S; Fang J; Dong H; Zhu C
Head Neck; 2023 Jul; 45(7):1654-1662. PubMed ID: 37097909
[TBL] [Abstract] [Full Text] [Related]
2. Identification of potential LncRNAs as papillary thyroid carcinoma biomarkers based on integrated bioinformatics analysis using TCGA and RNA sequencing data.
Feng JL; Zheng WJ; Xu L; Zhou QY; Chen J
Sci Rep; 2023 Mar; 13(1):4350. PubMed ID: 36928327
[TBL] [Abstract] [Full Text] [Related]
3. Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications.
Li Y; He Y; Chen Y; He Z; Yang F; Xing C
Apoptosis; 2023 Apr; 28(3-4):576-593. PubMed ID: 36695983
[TBL] [Abstract] [Full Text] [Related]
4. RBM47/SNHG5/foxo3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma.
Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Lv C; Zhang H
Cell Death Dis; 2022 Mar; 13(3):270. PubMed ID: 35338124
[TBL] [Abstract] [Full Text] [Related]
5. MiR-940 promotes malignant progression of breast cancer by regulating foxo3.
Zhang H; Peng J; Lai J; Liu H; Zhang Z; Li X; Liang B; Chen X; Zou B; Lin S; Zhang L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32840296
[TBL] [Abstract] [Full Text] [Related]
6. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
[TBL] [Abstract] [Full Text] [Related]
7. Circular RNA circfoxo3 promotes prostate cancer progression through sponging miR-29a-3p.
Kong Z; Wan X; Lu Y; Zhang Y; Huang Y; Xu Y; Liu Y; Zhao P; Xiang X; Li L; Li Y
J Cell Mol Med; 2020 Jan; 24(1):799-813. PubMed ID: 31733095
[TBL] [Abstract] [Full Text] [Related]
8. Reduction of circular RNA foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.
Shen Z; Zhou L; Zhang C; Xu J
Cancer Lett; 2020 Jan; 468():88-101. PubMed ID: 31593800
[TBL] [Abstract] [Full Text] [Related]
9. Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated thyroid cancer.
Larisch R; Midgley JEM; Dietrich JW; Hoermann R
Exp Clin Endocrinol Diabetes; 2018 Sep; 126(9):546-552. PubMed ID: 29396968
[TBL] [Abstract] [Full Text] [Related]
10. TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of foxo3a.
Zhao W; Dai Y; Dai T; Xie T; Su X; Li J; Zhou X; Meng K; Zhao X
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):594-601. PubMed ID: 29080747
[TBL] [Abstract] [Full Text] [Related]
11. Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor foxo3a.
Qiang W; Sui F; Ma J; Li X; Ren X; Shao Y; Liu J; Guan H; Shi B; Hou P
Endocrine; 2017 Apr; 56(1):98-108. PubMed ID: 28220348
[TBL] [Abstract] [Full Text] [Related]
12. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells.
Yu W; Ni Y; Saji M; Ringel MD; Jaini R; Eng C
Hum Mol Genet; 2017 Apr; 26(7):1365-1375. PubMed ID: 28164237
[TBL] [Abstract] [Full Text] [Related]
13. CHIP promotes thyroid cancer proliferation via activation of the MAPK and AKT pathways.
Zhang L; Liu L; He X; Shen Y; Liu X; Wei J; Yu F; Tian J
Biochem Biophys Res Commun; 2016 Aug; 477(3):356-62. PubMed ID: 27342662
[TBL] [Abstract] [Full Text] [Related]
14. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
[TBL] [Abstract] [Full Text] [Related]
15. ZIC1 is a putative tumor suppressor in thyroid cancer by modulating major signaling pathways and transcription factor foxo3a.
Qiang W; Zhao Y; Yang Q; Liu W; Guan H; Lv S; Ji M; Shi B; Hou P
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1163-72. PubMed ID: 24684457
[TBL] [Abstract] [Full Text] [Related]
16. XB130 mediates cancer cell proliferation and survival through multiple signaling events downstream of Akt.
Shiozaki A; Shen-Tu G; Bai X; Iitaka D; De Falco V; Santoro M; Keshavjee S; Liu M
PLoS One; 2012; 7(8):e43646. PubMed ID: 22928011
[TBL] [Abstract] [Full Text] [Related]
17. FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma.
Bellelli R; Castellone MD; Garcia-Rostan G; Ugolini C; Nucera C; Sadow PM; Nappi TC; Salerno P; Cantisani MC; Basolo F; Gago TA; Salvatore G; Santoro M
Endocr Relat Cancer; 2012 Oct; 19(5):695-710. PubMed ID: 22919068
[TBL] [Abstract] [Full Text] [Related]
18. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.
Wang P; Dong Q; Zhang C; Kuan PF; Liu Y; Jeck WR; Andersen JB; Jiang W; Savich GL; Tan TX; Auman JT; Hoskins JM; Misher AD; Moser CD; Yourstone SM; Kim JW; Cibulskis K; Getz G; Hunt HV; Thorgeirsson SS; Roberts LR; Ye D; Guan KL; Xiong Y; Qin LX; Chiang DY
Oncogene; 2013 Jun; 32(25):3091-100. PubMed ID: 22824796
[TBL] [Abstract] [Full Text] [Related]
19. foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies.
Marlow LA; von Roemeling CA; Cooper SJ; Zhang Y; Rohl SD; Arora S; Gonzales IM; Azorsa DO; Reddi HV; Tun HW; Döppler HR; Storz P; Smallridge RC; Copland JA
J Cell Sci; 2012 Sep; 125(Pt 18):4253-63. PubMed ID: 22718346
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of Akt/foxo3a signaling by constitutively active foxo3a suppresses growth of follicular thyroid cancer cell lines.
Hong ZY; Lee HJ; Shin DY; Kim SK; Seo M; Lee EJ
Cancer Lett; 2012 Jan; 314(1):34-40. PubMed ID: 21974806
[TBL] [Abstract] [Full Text] [Related]
[Next]
